학술논문

Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JAN 20 2015, 33 3, 1p. Supplement: S
Subject
Language
English
ISSN
15277755